UVM/FAHC — Burlington, Vermont

UVM/FAHC is a clinical research site located in Burlington, Vermont, United States 05401.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

UVM/FAHC has participated in 3 clinical trials.

Therapeutic areas: Neuroblastoma, Medulloblastoma, Relapse.

Sponsors: Giselle Sholler.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Burlington

Browse all research sites in Vermont · View every site in Burlington

• University of Vermont Medical Center, Fletcher Allen Health Care
• Vermont Lung Center at the University of Vermont
• Vaccine Testing Center, University of Vermont
• University of Vermont, Department of Neurology, 89 Beaumont Drive, Given Bldg, Room C-225
• University of Vermont/Vermont Children's Hospital
• The University of Vermont Medical Center
• University of Vermont & State Agricultural College
• The University of Vermont College of Medicine
• Substance Abuse Treatment Center, University of Vermont; UHC
• University Associates in Cardiology
• University of Vermont College of Medicine / Fletcher Allen Health Care
• University of Vemont Medical Center

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UVM/FAHC?

UVM/FAHC has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UVM/FAHC conducted?

UVM/FAHC has 3 clinical trials on record. Their work covers Neuroblastoma, Medulloblastoma, Relapse.

Is UVM/FAHC accredited by Crixeo Clinical Trials?

UVM/FAHC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UVM/FAHC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.